Quercetin protects human brain microvascular endothelial cells from fibrillar β-amyloid1-40-induced toxicity

Acta Pharmaceutica Sinica B

Volumn 5, Issue 1, 2015, Pages 47-54

  Li, Yongjie ^a   Zhou, Sibai ^a   Li, Jinze ^a   Sun, Yuhua ^b   Hasimu, Hamlati ^b   Liu, Rui ^a,b   Zhang, Tiantai ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b Xinjiang Institute of Materia Medica   (China)

Author keywords

Alzheimer's disease; Fibrillar A 1 40; Human brain microvascular endothelial cells; Quercetin

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; LACTATE DEHYDROGENASE; QUERCETIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ARTICLE; BRAIN CAPILLARY ENDOTHELIAL CELL; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ELECTRIC RESISTANCE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROPROTECTION; OXIDATIVE STRESS;

EID: 84942292290     PISSN: 22113835     EISSN: 22113843     Source Type: Journal    
DOI: 10.1016/j.apsb.2014.12.003     Document Type: Article

References (44)

1. Kalaria R.N. The blood-brain barrier and cerebral microcirculation in Alzheimer disease. Cerebrovasc Brain Metab Rev 1992, 4:226-260.
2. Ghiso J., Fossati S., Rostagno A. Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells. J Alzheimers Dis 2014, 42 Suppl:S167-S176.
3. Parham C., Auckland L., Rachwal J., Clarke D., Bix G. Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function. J Alzheimers Dis 2014, 38:415-423.
4. Sagare A.P., Bell R.D., Zlokovic B.V. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer[U+05F3]s disease. J Alzheimers Dis 2013, 33 Suppl. 1:S87-S100.
5. Liu R., Meng F.R., Zhang L., Liu A.L., Qin H.L., Lan X., et al. Luteolin isolated from the medicinal plant Elsholtzia rugulosa (Labiatae) prevents copper-mediated toxicity in β-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Molecules 2011, 16:2084-2096.
6. Grammas P., Yamada M., Zlokovic B. The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer[U+05F3]s disease. J Alzheimers Dis 2002, 4:217-223.
7. Grinberg L.T., Thal D.R. Vascular pathology in the aged human brain. Acta neuropathol 2010, 119:277-290.
8. Deane R., Zlokovic B.V. Role of the blood-brain barrier in the pathogenesis of Alzheimer[U+05F3]s disease. Curr Alzheimer Res 2007, 4:191-197.
9. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., et al. RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003, 9:907-913.
10. Liu R., Wu C.X., Zhou D., Yang F., Tian S., Zhang L., et al. Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis. BMC Med 2012, 10:105.
11. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer[U+05F3]s disease. Nature 1996, 382:685-691.
12. Morris A.W., Carare R.O., Schreiber S., Hawkes C.A. The cerebrovascular basement membrane: role in the clearance of β-amyloid and cerebral amyloid angiopathy. Front Aging Neurosci 2014, 6:251.
13. Fossati S., Ghiso J., Rostagno A. Insights into caspase-mediated apoptotic pathways induced by amyloid-β in cerebral microvascular endothelial cells. Neurodegener Dis 2012, 10:324-328.
14. Lee J.K., Jin H.K., Park M.H., Kim B.R., Lee P.H., Nakauchi H., et al. Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer[U+05F3]s disease. J Exp Med 2014, 211:1551-1570.
15. More S.S., Vince R. Potential of a γ-glutamyl-transpeptidase-stable glutathione analogue against amyloid-β toxicity. ACS Chem Neurosci 2012, 3:204-210.
16. Ansari M.A., Abdul H.M., Joshi G., Opii W.O., Butterfield D.A. Protective effect of quercetin in primary neurons against Aβ(1-42): relevance to Alzheimer[U+05F3]s disease. J Nutr Biochem 2009, 20:269-275.
17. Choi R.C., Zhu J.T., Leung K.W., Chu G.K., Xie H.Q., Chen V.P., et al. A flavonol glycoside, isolated from roots of Panax notoginseng, reduces amyloid-beta-induced neurotoxicity in cultured neurons: signaling transduction and drug development for Alzheimer[U+05F3]s disease. J Alzheimers Dis 2010, 19:795-811.
18. Jiménez-Aliaga K., Bermejo-Bescós P., Benedí J., Martín-Aragón S. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci 2011, 89:939-945.
19. Liu R., Zhang T.T., Zhou D., Bai X.Y., Zhou W.L., Huang C., et al. Quercetin protects against the Aβ(25-35)-induced amnesic injury: involvement of inactivation of rage-mediated pathway and conservation of the NVU. Neuropharmacology 2013, 67:419-431.
20. Huebbe P., Wagner A.E., Boesch-Saadatmandi C., Sellmer F., Wolffram S., Rimbach G. Effect of dietary quercetin on brain quercetin levels and the expression of antioxidant and Alzheimer[U+05F3]s disease relevant genes in mice. Pharmacol Res 2010, 61:242-246.
21. Tongjaroenbuangam W., Ruksee N., Chantiratikul P., Pakdeenarong N., Kongbuntad W., Govitrapong P. Neuroprotective effects of quercetin, rutin and okra (Abelmoschus esculentus Linn.) in dexamethasone-treated mice. Neurochem Int 2011, 59:677-685.
22. Veszelka S., Pásztói M., Farkas A.E., Krizbai I., Ngo T.K., Niwa M., et al. Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages. Neurochem Int 2007, 50:219-228.
23. Zhao L., Hou L., Sun H.J., Yan X., Sun X.F., Li J.G., et al. Apigenin isolated from the medicinal plant Elsholtzia rugulosa prevents β-amyloid 25-35-induces toxicity in rat cerebral microvascular endothelial cells. Molecules 2011, 16:4005-4019.
24. Vargo M.A., Voss O.H., Poustka F., Cardounel A.J., Grotewold E., Doseff A.I. Apigenin-induced-apoptosis is mediated by the activation of PKC δ and caspases in leukemia cells. Biochem Pharmacol 2006, 72:681-692.
25. Deli M.A., Veszelka S., Csiszár B., Tóth A., Kittel A., Csete M., et al. Protection of the blood-brain barrier by pentosan against amyloid-β-induced toxicity. J Alzheimers Dis 2010, 22:777-794.
26. Liu R., Li J.Z., Song J.K., Sun J.L., Li Y.J., Zhou S.B., et al. Pinocembrin protects human brain microvascular endothelial cells against fibrillar amyloid-β(1-40) injury by suppressing the MAPK/NF-κB inflammatory pathways. BioMed Res Int 2014, 2014:470393.
27. Deng J., Qi X.L., Guan Z.Z., Yan X.M., Huang Y., Wang Y.L. Pretreatment of SH-SY5Y cells with dicaffeoylquinic acids attenuates the reduced expression of nicotinic receptors, elevated level of oxidative stress and enhanced apoptosis caused by β-amyloid peptide. J Pharm Pharmacol 2013, 65:1736-1744.
28. 2: protective role of autophagy. Toxicol In Vitro 2013, 27:1780-1788.
29. Carrano A., Hoozemans J.J.M., van der Vies S.M., Rozemuller A.J.M., van Horssen J., de Vries H.E. Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal 2011, 15:1167-1178.
30. Strazielle N., Ghersi-Egea J.F., Ghiso J., Dehouck M.P., Frangione B., Patlak C., et al. In vitro evidence that β-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability. J Neuropathol Exp Neurol 2000, 59:29-38.
31. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer[U+05F3]s disease. Acta Neuropathol 2009, 118:103-113.
32. Thal D.R., Griffin W.S., de Vos R.A., Ghebremedhin E. Cerebral amyloid angiopathy and its relationship to Alzheimer[U+05F3]s disease. Acta Neuropathol 2008, 115:599-609.
33. Song Y., Liu J., Zhang F., Zhang J., Shi T., Zeng Z. Antioxidant effect of quercetin against acute spinal cord injury in rats and its correlation with the p38MAPK/iNOS signaling pathway. Life Sci 2013, 92:1215-1221.
34. Liu D., Hu H., Lin Z., Chen D., Zhu Y., Hou S., et al. Quercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo. J Photochem Photobiol B 2013, 127:8-17.
35. Yin Y., Li W., Son Y.O., Sun L., Lu J., Kim D., et al. Quercitrin protects skin from UVB-induced oxidative damage. Toxicol Appl Pharmacol 2013, 269:89-99.
36. Suganya N., Bhakkiyalakshmi E., Suriyanarayanan S., Paulmurugan R., Ramkumar K.M. Quercetin ameliorates tunicamycin-induced endoplasmic reticulum stress in endothelial cells. Cell Prolif 2014, 47:231-240.
37. Nekohashi M., Ogawa M., Ogihara T., Nakazawa K., Kato H., Misaka T., et al. Luteolin and quercetin affect the cholesterol absorption mediated by epithelial cholesterol transporter niemann-pick c1-like 1 in caco-2 cells and rats. PLoS One 2014, 9:e97901.
38. Seok S.M., Kim J.M., Park T.Y., Baik E.J., Lee S.H. Fructose-1,6-bisphosphate ameliorates lipopolysaccharide-induced dysfunction of blood-brain barrier. Arch Pharm Res 2013, 36:1149-1159.
39. Fischer S., Renz D., Schaper W., Karliczek G.F. In vitro effects of fentanyl, methohexital, and thiopental on brain endothelial permeability. Anesthesiology 1995, 82:451-458.
40. Gloor S.M., Wachtel M., Bolliger M.F., Ishihara H., Landmann R., Frei K. Molecular and cellular permeability control at the blood-brain barrier. Brain Res Brain Res Rev 2001, 36:258-264.
41. Lawrenson R., Williams T., Farmer R. Clinical information for research: the use of general practice databases. J Public Health Med 1999, 21:299-304.
42. Kugelman A., Choy H.A., Liu R., Shi M.M., Gozal E., Forman H.J. gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Respir Cell Mol Biol 1994, 11:586-592.
43. Das M., Singh S.V., Mukhtar H., Awasthi Y.C. Differential inhibition of rat and human glutathione S-transferase isoenzymes by plant phenols. Biochem Biophys Res Commun 1986, 141:1170-1176.
44. Yu S., Iwatsuki H., Ichinohe N., Mori F., Shoumura K. 'In vivo perfusion Turnbull[U+05F3]s reaction' for Fe (II) histochemistry in non-anoxic/non-ischemic and anoxic/ischemic cat brains. Neurosci Lett 2001, 308:79-82.